Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 12, 2022

BUY
$1.82 - $3.5 $109 - $210
60 New
60 $3,000
Q4 2020

Feb 10, 2021

SELL
$3.03 - $5.51 $54,540 - $99,180
-18,000 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$2.9 - $4.29 $49,300 - $72,930
-17,000 Reduced 48.57%
18,000 $22,000
Q2 2020

Aug 10, 2020

BUY
$1.99 - $3.64 $58,705 - $107,380
29,500 Added 536.36%
35,000 $27,000
Q1 2020

May 21, 2020

BUY
$0.28 - $6.23 $1,540 - $34,265
5,500 New
5,500 $2,000

Others Institutions Holding GNPX

About Genprex, Inc.


  • Ticker GNPX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,300
  • Market Cap $42.3M
  • Description
  • Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...
More about GNPX
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.